In human colon tumors, the UDG activity has been reported to be significantly higher than in normal bowel tissues [29], suggesting UDG as a potential biomarker to predict 5-FdU resistance in colon cancer and also a potential target for inhibition. The gene discussed is UNG; the disease is malignant colon neoplasm.